The two explanations for what GHK-Cu does, the evidence each side points to, and why the question is still open

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Two hypotheses explain the actions attributed to GHK-Cu. The copper-delivery hypothesis, from the carrier work of the 1980s, holds that the peptide ferries copper into cells where copper enzymes — lysyl oxidase, superoxide dismutase, cytochrome oxidase — need it, and that the biological effects are copper effects made efficient by the carrier. The signalling hypothesis holds that the tripeptide is a fragment released from matrix proteins such as collagen and SPARC when tissue is damaged, that cells recognise it as a signal of injury, and that copper stabilises the active conformation. The culture evidence that neither component alone reproduces the effect is consistent with both. No receptor for GHK has been identified, and the question remains open.

For copper delivery

The binding affinity comparable to albumin; the structural resemblance to the albumin copper site; the dependence of matrix cross-linking on copper enzymes; the SOD-like chemistry of the complex; and the observation that free copper salts, which cells take up poorly and which are toxic, are far less effective in culture than the complex. On this view GHK is a delivery vehicle and the pharmacology is that of copper.

The weakness: cells have dedicated copper uptake systems and histidine already serves as a small carrier.

For peptide signalling

The sequence occurs in collagen alpha chains and in the matricellular protein SPARC and could be released by proteolysis at a wound; the genome-wide expression study found changes in thousands of genes in a pattern unlike that of copper alone; and some effects are reported with the free peptide at higher concentration. On this view the peptide is a matrikine — a matrix fragment with signalling activity — and copper is a cofactor.

The weakness: no receptor, and the expression study is in one cell type without a copper-matched control.

Why it is here

Because the compound is sold and discussed as if its mechanism were known, and it is not. The pages on each strand of evidence are linked. It describes hypotheses and no use of the pack.

GHK-Cu is supplied by REVIVE LAB UAE for laboratory research use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
GHK-Cu Pack50 mgAED 425In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

For copper delivery?

The binding affinity comparable to albumin; the structural resemblance to the albumin copper site; the dependence of matrix cross-linking on copper enzymes; the SOD-like chemistry of the complex; and the observation that free copper salts, which cells take up poorly and which are toxic, are far less effective in culture than the complex. On this view GHK is a delivery vehicle and the pharmacology is that of copper.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

GHK-Cu Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.